1. A dose ranging study of 2 different formulations of 15-valent pneumococcal conjugate vaccine (PCV15) in healthy infants. Issue 3 (4th March 2019) Authors: Rupp, R.; Hurley, D.; Grayson, S.; Li, J.; Nolan, K.; McFetridge, R.D.; Hartzel, J.; Abeygunawardana, C.; Winters, M.; Pujar, H.; Benner, P.; Musey, L. Journal: Human vaccines & immunotherapeutics Issue: Volume 15:Issue 3(2019) Page Start: 549 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P1576: A PHASE 3 RANDOMIZED, DOUBLE-BLIND, COMPARATOR-CONTROLLED STUDY TO EVALUATE SAFETY, TOLERABILITY AND IMMUNOGENICITY OF V114 PNEUMOCOCCAL VACCINE IN HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS (PNEU-STEM). (23rd June 2022) Authors: Wilck, M.; Cornely, O.; Ljungman, P.; Cordonnier, C.; Diego Velez, J.; Dagan, R.; Richmond, P.; Chen, Q.; Daus, C.; Geddie, K.; Sterling, T.; Shekar, T.; Musey, L.; Buchwald, U. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1457 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗